- Home
- WOW vs AURA Comparison
WOW vs AURA Comparison
Compare WOW & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOW
- AURA
- Stock Information
- Founded
- WOW 2001
- AURA 2007
- Country
- WOW United States
- AURA United States
- Employees
- WOW N/A
- AURA N/A
- Industry
- WOW Cable & Other Pay Television Services
- AURA Biotechnology: Pharmaceutical Preparations
- Sector
- WOW Telecommunications
- AURA Health Care
- Exchange
- WOW Nasdaq
- AURA Nasdaq
- Market Cap
- WOW 441.7M
- AURA 396.8M
- IPO Year
- WOW 2017
- AURA 2021
- Fundamental
- Price
- WOW $5.16
- AURA $5.95
- Analyst Decision
- WOW Hold
- AURA Strong Buy
- Analyst Count
- WOW 2
- AURA 7
- Target Price
- WOW $5.20
- AURA $22.29
- AVG Volume (30 Days)
- WOW 987.9K
- AURA 290.8K
- Earning Date
- WOW 11-03-2025
- AURA 11-11-2025
- Dividend Yield
- WOW N/A
- AURA N/A
- EPS Growth
- WOW N/A
- AURA N/A
- EPS
- WOW N/A
- AURA N/A
- Revenue
- WOW $604,800,000.00
- AURA N/A
- Revenue This Year
- WOW N/A
- AURA N/A
- Revenue Next Year
- WOW N/A
- AURA N/A
- P/E Ratio
- WOW N/A
- AURA N/A
- Revenue Growth
- WOW N/A
- AURA N/A
- 52 Week Low
- WOW $3.06
- AURA $4.35
- 52 Week High
- WOW $5.78
- AURA $12.38
- Technical
- Relative Strength Index (RSI)
- WOW 63.16
- AURA 41.63
- Support Level
- WOW $5.10
- AURA $5.93
- Resistance Level
- WOW $5.18
- AURA $6.28
- Average True Range (ATR)
- WOW 0.04
- AURA 0.27
- MACD
- WOW -0.03
- AURA -0.00
- Stochastic Oscillator
- WOW 41.38
- AURA 27.12
About WOW WideOpenWest Inc.
WideOpenWest Inc is a cable operator and broadband service, provider. The company serves residential, business and wholesale customers in Illinois, Michigan, Indiana, Ohio, Kansas, Tennessee, Maryland, and South Carolina. Its service portfolio consists of high-speed internet, data, voice, cloud, and cable television services. The company operates in one business segment that is Broadband Services. The majority of the revenue is generated from the subscription service revenue received.
About AURA Aura Biosciences Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.